PPLPHARMA — Piramal Pharma (Mumbai) Share News
0.000.00%
Last trade - 00:00- IN₹262.00bn
- IN₹304.53bn
- IN₹88.69bn
Brief: Piramal Pharma Approves Sale Of Unit For 85 Million Rupees
Brief: Piramal Pharma Unit Receives $2.4 Mln In Settlement From Astral
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Brief: Carlyle Group May Sell Up To 10% Stake In India's Piramal Pharma Via Block Deals, Moneycontrol reports
Carlyle to sell up to 10% stake in Piramal Pharma, Moneycontrol reports (updated)
Carlyle to sell up to 10% stake in Piramal Pharma, Moneycontrol reports
India's Piramal Pharma gains on anti-dumping duty on Vitamin-A Palmitate imports
China robotaxis, Indian pharma among hedge fund top picks at Sohn Hong Kong
Brief: Piramal Pharma March-Qtr Consol Net Profit 1.54 Bln Rupees
Brief: Piramal Pharma Continues To Invest $90 Mln In Expansion Of Two US Sites
India's Piramal Pharma rises after Goldman Sachs initiates with "buy"
India's Piramal Pharma rises on UK nod for drug to treat hypotension in infants
Brief: Piramal Pharma Says Piramal Critical Care And BrePco Announces MHRA Approval For Neoatrico In UK
India's Piramal Enterprises hit with nearly $172 million tax bill for pharma deal (updated)
India's contract drug makers seek government support in China fight
At conference, drugmakers tout AI efforts as US tariffs cast shadow
Brief: Piramal Pharma Says US FDA Inspection At Turbhe Facility
Brief: Piramal Pharma Dec-Qtr Consol Net Profit 36.8 Mln Rupees